Amylyx Pharmaceuticals (Nasdaq: AMLX) announced it will report its fourth quarter and full year 2025 financial results on Tuesday, March 3, 2026. The company’s senior management will host a conference call and audio webcast at 8:00 a.m. ET to discuss these results and provide other company updates. Interested parties can access the call via phone or a live audio webcast on Amylyx’s investor relations website, with a replay available for 90 days.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Amylyx Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026
Amylyx Pharmaceuticals (Nasdaq: AMLX) announced it will report its fourth quarter and full year 2025 financial results on Tuesday, March 3, 2026. The company’s senior management will host a conference call and audio webcast at 8:00 a.m. ET to discuss these results and provide other company updates. Interested parties can access the call via phone or a live audio webcast on Amylyx’s investor relations website, with a replay available for 90 days.